Site-specific gene delivery in vivo through engineered Sendai viral envelopes

scientific article

Site-specific gene delivery in vivo through engineered Sendai viral envelopes is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1998PNAS...9511886R
P356DOI10.1073/PNAS.95.20.11886
P932PMC publication ID21735
P698PubMed publication ID9751760
P5875ResearchGate publication ID13533746

P2093author name stringSarkar DP
Hasnain SE
Venkaiah B
Ramani K
Hassan Q
P2860cites workA 45,000-M(r) glycoprotein in the Sendai virus envelope triggers virus-cell fusionQ27480846
Firefly luciferase gene: structure and expression in mammalian cellsQ29616519
Reconstituted viral envelopes--'Trojan horses' for drug delivery and gene therapy?Q35287725
Targeted and nontargeted liposomes for in vivo transfer to rat liver cells of a plasmid containing the preproinsulin I geneQ37508435
Tissue Targeting of Multivalent LeX-terminated N-Linked Oligosaccharides in MiceQ38290387
F protein induced fusion of Sendai viral envelopes with mouse teratocarcinoma cells through Le(x)-Le(x) interactionQ39463043
Biochemical and functional characterization of DNA complexes capable of targeting genes to hepatocytes via the asialoglycoprotein receptorQ41120963
Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal periodQ41157449
Fusion-mediated microinjection of lysozyme into HepG2 cells through hemagglutinin neuraminidase-depleted Sendai virus envelopes.Q41493721
Improved DNA: liposome complexes for increased systemic delivery and gene expressionQ41633695
How do viruses enter cells? The HIV coreceptors teach us a lesson of complexityQ41670718
Bifunctionality of the AcMNPV homologous region sequence (hr1): enhancer and ori functions have different sequence requirementsQ42063806
In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression.Q44402352
Gene therapy -- promises, problems and prospectsQ45883584
Novel gene delivery to liver cells using engineered virosomesQ59443245
Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expressionQ64383560
Large-scale isolation of covalently closed circular DNA using gel filtration chromatographyQ70225483
Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomyQ70722768
Isolation of detergent-extracted Sendai virus proteins by gel-filtration, ion-exchange and reversed-phase high-performance liquid chromatography and the effect on immunological activityQ72397922
P433issue20
P407language of work or nameEnglishQ1860
P1104number of pages5
P304page(s)11886-11890
P577publication date1998-09-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleSite-specific gene delivery in vivo through engineered Sendai viral envelopes
P478volume95

Reverse relations

cites work (P2860)
Q41948325A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion
Q38297491An internal segment (residues 58-119) of the hepatitis B virus X protein is sufficient to activate MAP kinase pathways in mouse liver
Q40159983Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.
Q34084752Current status of pH-sensitive liposomes in drug delivery
Q63246400Delivery technologies for cancer immunotherapy
Q36293328Development of HVJ envelope vector and its application to gene therapy
Q44631057Development of a Virosome Vaccine for Newcastle Disease Virus
Q64093774Gene Therapy Leaves a Vicious Cycle
Q34107177Gene therapy for dyslipidemia: clinical prospects
Q40387559Histidylated lipid-modified Sendai viral envelopes mediate enhanced membrane fusion and potentiate targeted gene delivery
Q42540967Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy
Q33870289Liver-directed gene therapy: promises, problems and prospects at the turn of the century
Q34240331Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon
Q33804080Mucosal immunization with DNA vaccines
Q39738109Reciprocal regulation of AKT and MAP kinase dictates virus-host cell fusion
Q40885940Selective virus-mediated intracellular delivery of membrane-impermeant compounds by means of plasma membrane vesicles
Q45325609Sendai virus recruits cellular villin to remodel actin cytoskeleton during fusion with hepatocytes
Q33848045Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo
Q42816691Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes.
Q36552842Targeting ribosome assembly on the HCV RNA using a small RNA molecule
Q33857121The potential of gene therapy in the treatment of hepatocellular carcinoma
Q56057560Tools for translation: non-viral materials for therapeutic mRNA delivery
Q34019880Virosomes: evolution of the liposome as a targeted drug delivery system